[ACRX] QoQ Quarter Result on 30-Sep-2013 [#Q3]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
05-Nov-2013
Financial Year
2013
Quarter
30-Sep-2013 [#Q3]
Profit Trend
QoQ- 37.03%
YoY- -28.01%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Revenue 71 95 27,607 548 407 940 1,675 -87.91%
PBT -10,575 -9,631 17,769 -10,986 -17,447 -12,762 -33,363 -53.60%
Tax 2,215 -618 -1,742 -1,980 -9,273 -1,285 -22,841 -
NP -10,575 -9,631 17,769 -10,986 -17,447 -12,762 -10,522 0.33%
Tax Rate - - 9.80% - - - - -
Total Cost 10,646 9,726 9,838 11,534 17,854 13,702 12,197 -8.69%
Ratio Analysis
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
NP Margin -14,894.37 -10,137.89 64.36 -2,004.74 -4,286.73 -1,357.66 -628.18 730.12%
Per Share
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
EPS -4.88 -4.46 8.20 -5.30 -9.36 -6.87 -5.67 -9.54%
EPS Diluted -4.77 -4.46 8.20 -5.30 -9.36 -6.87 -5.67 -10.91%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.